Skip to main content
Thomas Sutula, MD, Neurology, Madison, WI

Thomas P Sutula MD PhD

Neurology•Madison, WI

Epilepsy

Professor of Neurology, Department of Neurology, University of Wisconsin, 1995-present

Join to view full profile

  • Dept. of Neurology, 7251 MFCB, Univ. of Wisconsin1685 Highland AvenueMadison, WI 53705

Dr. Sutula is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Sutula's full profileAlready have an account?

Summary

  • Dr. Thomas Sutula is a neurologist based in Madison, WI, with subspecialty expertise in epilepsy. He completed his medical education at the Perelman School of Medicine at the University of Pennsylvania and pursued residencies in Internal Medicine at Washington University/B-JH/SLCH Consortium and Neurology at the University of Virginia Medical Center. Dr. Sutula has authored more than 100 publications with a major focus on understanding how activity-dependent plasticity in neural circuits and metabolism influence epilepsy. He has served as President of the American Epilepsy Society (AES) and the American Society of Experimental Neural Therapeutics (ASENT). His work has been recognized with awards including the Founders (William Lennox) Award from the American Epilepsy Society, the Clarence Shaffrey Award from St. Joseph's University. He is co-founder and and Chief Scientific Officer of Hexokine Therapeutics Inc. which is developing metabolic approaches to treatment of seizures and traumatic brain injury.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Neurology, 1978 - 1981
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1978
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1975

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1984 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • William Lennox Award American Epilepsy Society, 2010
  • Clarence Shaffrey Award St. Joseph's University, 2011
  • Sabbatical Research Award, Wellcome Institute for Cancer and Developmental Biology, Cambridge UK American Epilepsy Society, 1995

Publications & Presentations

PubMed

Books/Book Chapters

  • “Do Seizures Damage The Brain” - Progress in Brain Research, vol.135 
    Chapter: Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits 
    Page 95 - 110R. Kotloski, M. Lynch , S. Lauersdorf, T. SutulaEditors: ed. T.Sutula, A. Pitkänen.Elsevier, AmsterdamEdition 135,2002
  • Neurology Pearls 
    A. Waclawik, T. SutulaHanley & Belfus, Philadelphia2000

Other

  • Methods and pharmaceutical compositions for treating adverse or deleterious sequellae of traumatic brain injury 
    E. Hutchinson, M. Meyerand, P. Rutecki, T. Sutula, US Patent No. 8,633,165
    2010
  • Metabolic-based Methods for Modulating Gene Expression 
    A. Roopra, B. Schoenike, T. Sutula, US Patent No.7557085
    2005
  • Compounds and Methods for Treating Seizure Disorders 
    S.Kriegler, A. Roopra, C.Stafstrom, T.Sutula, US Patent No. 06979675
    1/1/2004

Grant Support

  • IND-enabling studies of 2DG for prevention of post-traumatic epilepsy in plasticity-susceptible rats”Citizens United for Research in Epilepsy (CURE)2015–2018
  • “Mechanisms of 2DG’s Antiepileptic Effects” (Co-PI with P. Rutecki, MD)Veterans Administration Merit Award2014–2018
  • “IND-enabling preclinical studies of 2DG for treatment of epilepsy”National Center for Advancing Translational Science and the National Institute for Neurological Disorders and Stroke2010–2016
  • Prediction, Detection, and Prevention of Post-Traumatic Epilepsy and PTSD in Genetically Susceptible RatsUS Department of Defense, Deployment Related Medical Research Program2009–2012
  • Hippocampal Plasticity And EpilepsyNational Institute Of Neurological Disorders And Stroke2005–2008

Professional Memberships

Industry Relationships

  • Co-Founder, Chief Scientific Officer, Hexokine Therapeutics Inc.Hexokine Therapeutics Inc. is a biotech start-up advancing metabolic therapies for treatment of CNS disorders including status epilepticus, epilepsy, and TBI.2022 - Present

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Thomas Sutula, Dr. Thomas Sutula, MD, Dr. T Sutula, Dr. Thomas P Sutula